Good participatory practice for coronavirus disease 2019 (COVID-19) research: the case of a COVID-19 prevention study
<strong>Background: </strong>The COPCOV study (chloroquine/ hydroxychloroquine prevention of coronavirus disease), which started recruitment in April 2020, is a multi-country double-blind, randomised, placebo-controlled trial which is being conducted in healthcare facilities involved in...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
F1000Research
2022
|